N@N

Market Maker Surveillance Report. DCO, AMRS, ALXA, IMSC, ALIM, HZNP, Winning Stocks With Lowest Price Friction For Monday, Jun

June 25, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3577 companies with "abnormal" market making, 1452 companies with positive Friction Factors and 4271 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. DUCOMMUN INC (NYSE:DCO), AMYRIS INC (NASDAQ:AMRS), ALEXZA PHARMACEUTICALS INC (NASDAQ:ALXA), IMPLANT SCIENCES CORP (OTC:IMSC), ALIMERA SCIENCES INC (NASDAQ:ALIM), (NASDAQ:HZNP). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  DCO     $0.940    11.85%    72,666       34.37%    65,095       30.79%    7,571        81      
  AMRS    $0.680    20.67%    1,589,539    53.96%    1,350,962    45.86%    238,577      3,508   
  ALXA    $0.650    16.37%    1,690,185    49.61%    1,686,273    49.49%    3,912        60      
  IMSC    $0.150    15.00%    331,240      63.09%    145,930      27.80%    185,310      12,354  
  ALIM    $0.440    15.88%    145,765      58.28%    104,351      41.72%    41,414       941     
  HZNP    $0.950    18.03%    1,184,967    56.12%    902,732      42.75%    282,235      2,971   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows DCO with a dollar gain Monday of $0.94000 and a Friction Factor of 81 shares. That means that it only took 81 more shares of buying than selling to move DCO higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

DUCOMMUN INC (NYSE:DCO) - Ducommun Incorporated, through its subsidiaries, designs, engineers, and manufactures aerostructure, and electromechanical components and subassemblies. The company offers aluminum stretch-forming, titanium and aluminum hot-forming, machining, composite lay-up, metal bonding, and chemical milling services. It also provides illuminated push button switches and panels, microwave and milli-meterwave switches and filters, fractional horsepower motors and resolvers, and mechanical and electromechanical subassemblies, as well as provides engineering, technical, and program management services. Ducommun Incorporated serves the United States and foreign commercial and military aircraft, helicopter, missile, and related programs, as well as space programs. The company was founded in 1849 and is based in Carson, California.

AMYRIS INC (NASDAQ:AMRS) - Amyris, Inc., an integrated renewable products company, offers renewable compounds for a variety of markets. It builds and applies its industrial synthetic biology platform to provide alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. The company modifies microorganisms, primarily yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into a variety of hydrocarbon molecules. It focuses its commercialization efforts on a molecule called farnesene or Biofene, which forms the basis for a range of products comprising detergents, cosmetics, perfumes, industrial lubricants, and diesel. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

ALEXZA PHARMACEUTICALS INC (NASDAQ:ALXA) - Alexza Pharmaceuticals, Inc., a development stage company, focuses on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are based on a proprietary technology, the Staccato system that vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. The companys clinical-stage product candidates comprise AZ-004 (staccato loxapine), which is licensed to Biovail Laboratories International SRL for the acute treatment of agitation in patients with schizophrenia or bipolar disorder; AZ-007 (staccato zaleplon), which completed phase I status for the treatment of insomnia; and AZ-001 (staccato prochlorperazine) and AZ-104 (staccato loxapine, low-dose), phase II product candidates for the treatment of migraine headache. It also develops AZ-002 (Staccato alprazolam), which completed a phase 1 clinical trial in healthy subjects and a phase 2a proof-of-concept clinical trial in panic disorder patients for the treatment of panic attacks; and AZ-003 (Staccato fentanyl) that completed phase 1 clinical trial for the treatment of patients with acute pain, including patients with breakthrough cancer pain and postoperative patients with acute pain episodes. The company was formerly known as Alexza Molecular Delivery Corporation and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals, Inc. was founded in 2000 and is based in Mountain View, California.

IMPLANT SCIENCES CORP (OTC:IMSC) - Implant Sciences Corporation engages in the development, manufacture, and sale of sensors and systems for the security, safety, and defense industries in the United States and internationally. The company offers handheld and bench-top explosive trace detection systems to private companies and government agencies for screening baggage, cargo, vehicles, people, and other objects for the detection of trace amounts of explosives. Implant Sciences Corporation was founded in 1984 and is headquartered in Wilmington, Massachusetts.

ALIMERA SCIENCES INC (NASDAQ:ALIM) - Alimera Sciences, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of ophthalmic pharmaceuticals. It develops pharmaceuticals for diseases affecting the back of the eye or retina. The companys product candidates include Iluvien, an intravitreal insert that provides a sustained therapeutic effect for up to 36 months in the treatment of diabetic macular edema; or DME, a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness, as well as other ophthalmic diseases, such as the wet form of age-related macular degeneration (AMD), the dry form of AMD, and retinal vein occlusion. It also conducts testing on two classes of Nicotinamide Adenine Dinucleotide Phosphate oxidase inhibitors. The company was founded in 2003 and is headquartered in Alpharetta, Georgia.

(NASDAQ:HZNP) -

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net